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Abstract 27 
We determined the effect of suppressing lipolysis via administration of nicotinic acid (NA) 28 
on fuel substrate selection and half-marathon running capacity. In a single-blinded Latin 29 
square design, 12 competitive runners completed four trials involving treadmill running until 30 
volitional fatigue at a pace based on 95% of personal best half-marathon time. Trials were 31 
completed in a fed or overnight fasted state: 1) Carbohydrate (CHO) ingestion before (2 g 32 
CHO·kg·BM-1), and during (44 g·h-1) [CFED]; 2) CFED plus NA ingestion [CFED-NA]; 3) 33 
fasted with placebo ingestion during [FAST] 4) FAST plus NA ingestion [FAST-NA]. There 34 
was no difference in running distance (CFED 21.53 ± 1.07, CFED-NA 21.29 ± 1.69, FAST 35 
20.60 ± 2.09, FAST-NA 20.11 ± 1.71 km) or time to fatigue between the four trials. Plasma 36 
free fatty acids (FFA) and glycerol concentrations were suppressed following NA ingestion 37 
irrespective of pre-exercise nutritional intake but were higher throughout exercise in FAST 38 
compared to all other trials (P<0.05). Rates of whole body CHO oxidation were unaffected 39 
by NA ingestion for CFED and FAST, but were lower in FAST compared to CFED-NA 40 
(P<0.05). CHO was the primary substrate for exercise in all conditions, contributing 83-91% 41 
to total energy expenditure with only a small contribution from fat-based fuels.  Blunting the 42 
exercise-induced increase in FFA via NA ingestion did not impair intense running capacity 43 
lasting ~85 min nor alter patterns of substrate oxidation in competitive athletes. While there 44 
was a small, but obligatory use of fat-, the oxidation of CHO-based fuels predominates during 45 
half-marathon running. 46 
Key words: Carbohydrate, high-intensity running, nicotinic acid, substrate utilization, 47 
performance. 48 
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Introduction 52 
The major goal of endurance training is to induce physiological adaptations that 53 
increase an athlete’s ability to sustain the highest average power output or speed of 54 
movement for a given distance or time (14), reduce the oxygen cost (V̇O2) of locomotion, and 55 
maintain a higher fractional utilization of maximal oxygen uptake (V̇O2max) during training 56 
and competition (9). Such adaptations depend, in part, on the rate at which chemical energy 57 
(i.e. fat and carbohydrate [CHO]) can be converted into mechanical energy for skeletal 58 
muscle contraction (14). In most endurance events, a mix of substrates and energy-producing 59 
pathways contribute to work outputs and athletes pursue training/dietary strategies that 60 
increase the overall capacity of these pathways, as well as implementing acute competition 61 
strategies that ensure optimal substrate availability to meet the energy cost of the event.  62 
While the absolute oxidation rate of all energy substrates increases at the high 63 
exercise intensities and power outputs sustained by athletes in training and competition, 64 
CHO-based fuels are the predominant energy source (4, 6, 17). However, recent attention has 65 
focused on diet-exercise strategies that reduce skeletal muscle dependence on CHO-based 66 
fuels (i.e. muscle and liver glycogen, blood glucose, lactate) before and during exercise, 67 
while concomitantly maximising fat oxidation (adipose and intra-muscular triglycerides 68 
[TGs], blood-borne free fatty acids [FFAs] and TGs) (33). It has been proposed that such 69 
strategies will enhance performance by promoting greater utilization of fat-based fuels, 70 
whose availability is relatively unlimited (33). However, even when these strategies promote 71 
rates of fat oxidation that are substantially higher than those achieved by the effects of 72 
endurance training alone, there is no clear evidence of a performance benefit (7, 13, 30). 73 
Indeed, rates of muscle fat oxidation are inadequate to support the high relative (70-90% 74 
V̇O2max) and absolute work rates sustained by competitive athletes during running or cycling 75 
events lasting < 2 h (17, 22, 32, 34). 76 
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An alternative strategy to test the role of fat availability to the performance of 77 
endurance sports is to investigate scenarios in which the muscle’s access to fatty substrates is 78 
impaired. Accordingly, in the present study we administered the pharmacological agent 79 
nicotinic acid (NA) during simulated half-marathon running in both fed and overnight-fasted 80 
states. We hypothesized that suppressing lipolysis via NA ingestion would not alter substrate 81 
selection or have a detrimental effect on half-marathon running capacity since CHO- and not 82 
fat-based fuels support optimal endurance exercise up to ~90 min. 83 
Methods 84 
Participants 85 
Twelve competitive male runners who had completed a half-marathon within the 86 
previous six months were recruited for this study. Participant characteristics were: age 31 ± 5 87 
(SD) y; body mass (BM) 70.8 ± 5.5 kg; V̇O2max 64.1 ± 3.4 ml·kg-1·min-1; personal best half-88 
marathon time (PB) 80:50 ± 4:12 min: s. At the time of the investigation, participants were 89 
running ~82 ± 32 km·wk-1. Participants were fully informed of all experimental procedures 90 
and possible risks before providing their written, informed consent. All participants 91 
completed a medical history questionnaire to ensure they were free from illness and injury 92 
prior to commencing the performance trials. The study was approved by the Human Research 93 
Ethics Committee of the Australian Catholic University. 94 
Preliminary testing and familiarisation 95 
Each participant completed an incremental test to volitional fatigue on a motorized 96 
treadmill (Pulsar 3p, HP Cosmos, Nussdorf-Traunstein, Germany) to determine V̇O2max.  97 
The test commenced at a speed of 12 km·h-1 with a 1% incline and increased by 2 km·h-1 98 
every two min until a speed of 16 km·h-1 was reached. Thereafter, the treadmill gradient was 99 
increased by 2% every two min until the participant reached volitional fatigue, determined as 100 
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the inability to maintain the prescribed speed. During the maximal test and the subsequent 101 
described performance trials, expired gas was collected via open-circuit spirometry (TrueOne 102 
2400, Parvo Medics, Utah, USA) and the instantaneous rates of O2 consumption (V̇O2), CO2 103 
production (V̇CO2) and the respiratory exchange ratio (RER) were calculated every 30 s from 104 
conventional equations (28). Before each test, gas analyzers were calibrated with 105 
commercially available gas mixtures (16% O2, 4% CO2) and volume flow was calibrated 106 
using a 3 L syringe. An individual’s V̇O2max was determined as the highest 30 s average 107 
which typically coincided with an inability to maintain the prescribed pace, an RER > 1.15 or 108 
a subjective rating of maximal effort (RPE). To familiarize participants to the trial protocol 109 
they completed a 10 km treadmill run within the 10 days prior to the first performance trial. 110 
The treadmill was set at a speed of 95% of individual best half-marathon (21.1 km) time 111 
attained in the last 6 months, with a gradient of 1%, to better simulate the metabolic cost of 112 
overground running (2). Expired gas was collected at 15 and 30 min and a CHO gel and 113 
placebo (PLC) capsules were administered at 25 min.  114 
Overview of study design 115 
In a single blinded Latin square design, each participant completed 4 performance 116 
trials in a randomized order separated by 10-14 d. Participants were blinded to the order of 117 
the trials. Each trial required running to volitional fatigue (i.e. the inability to maintain the 118 
prescribed speed) at a speed of 95% of their best half-marathon time attained in the last 6 119 
months, with a gradient of 1% (2). The 4 performance trials were completed following a pre-120 
exercise meal with different nutritional value: CHO ingestion before (2 g CHO·kg·BM-1) and 121 
during (44 g.h-1) (CFED); CFED plus NA ingestion (CFED-NA); overnight fasted, PLC meal 122 
before and PLC during (FAST); FAST with NA ingestion (FAST-NA).  123 
Exercise and diet control 124 
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Participants were instructed to refrain from any vigorous physical activity in the 48 h 125 
prior to a performance trial and to abstain from exercise in the 24 h before a trial. During this 126 
time, dietary standardization was achieved by providing participants with individualized pre-127 
packaged meals and snacks (daily intake of 8 g CHO·kg·BM-1, 2 g protein·kg·BM-1 and 1 g 128 
fat·kg·BM-1) (21) and by instructing them to abstain from caffeine (i.e. coffee, tea, energy 129 
drinks) and alcohol. On the day of a trial, participants were provided a standardized meal 130 
consisting of jelly and 600 mL of fluid (2 g CHO·kg·BM-1) or a visually identical, taste 131 
matched PLC of negligible energy value.  132 
Protocol  133 
On the morning of a performance trial, participants reported to the lab at 0700 h after 134 
a 10-12 h overnight fast (Figure 1). A cannula (22G, Terumo, Tokyo, Japan) was inserted 135 
into the antecubital vein of the left arm and a baseline blood sample (6 mL) was taken. 136 
Following each blood-draw, the cannula was flushed with saline (5 mL NaCl) to keep the 137 
vein patent. Participants then ingested either the CHO or PLC meal and rested for 120 min. 138 
Further blood samples were taken at -100 min, -12 min and immediately prior (0 min) to the 139 
performance trial. NA (10 mg·kg·BM-1 or 5 mg·kg·BM-1) or PLC (200 mg maltodextrin) 140 
capsules were administered 30 min (10 mg·kg·BM-1) and 15 min (5 mg·kg·BM-1) prior to the 141 
performance trial. Intermittent administration of NA was chosen to minimise the risk of 142 
negative circulatory effects which typically occur with a single bolus dose (27).  Participant’s 143 
BM was recorded prior to completing a 5-10 min warm up on the motorized treadmill at a 144 
self-selected pace, which remained the same for each individual for each trial. Participants 145 
commenced the performance trial 120 min following breakfast. During the performance trial, 146 
participants were unable to see elapsed time or distance, but were informed to run until they 147 
could no longer maintain the prescribed pace.  148 
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Blood samples (6 mL), rate of perceived exertion (RPE) (Borg 1973), heart rate (HR) (Polar 149 
Electro OY, Kempele, Finland) and expired gas were collected at 20 min intervals. 150 
Participants were instructed to inform the principal investigator when they were close to 151 
“fatigue”, so a final expired gas sample could be collected. Isotonic CHO (SiS GO Isotonic 152 
Gel, Blackburn, UK, 44 g CHO·h-1) or PLC gels and NA or PLC capsules were administered 153 
every 25 min and 30 min, respectively. Water was consumed ad libitum and the total volume 154 
consumed throughout each trial measured. On completion of a trial, participants filled out a 155 
questionnaire comprising a descriptive 9-point gastrointestinal discomfort scale (“no problem 156 
at all” to “worst it’s ever been”) to rate any distress experienced during the run (29).  157 
Blood analysis 158 
 Blood samples (6 mL) were collected into vacutainers containing EDTA and 159 
immediately analyzed for blood lactate and glucose concentrations using YSI 2300 STAT 160 
PlusTM. Following initial analysis, samples were centrifuged at 1500 g for 10 min at 4 ˚C and 161 
aliquots of plasma were stored at -80˚C for later FFA and glycerol analysis. Samples were 162 
analyzed for FFA concentration using a Non-esterified-fatty acid (NEFA) assay kit (Wako 163 
Pure Chemical Industries, Ltd, Osaka, Japan) and glycerol concentration using a glycerol 164 
assay kit (Sigma-Aldrich, Ltd, Australia) as per the manufacturer’s instructions.  165 
Rates of whole body substrate oxidation and total energy expenditure  166 
Rates of whole body CHO and fat oxidation (g.min-1) were calculated from each 167 
steady-state gas sample collected during the performance trial using conventional equations 168 
(28). The calculations were made from V̇O2 and V̇CO2 measurements using the non-protein 169 
RER equations below which are based on the assumption that V̇O2 and V̇CO2 accurately 170 
reflect tissue O2 consumption and CO2 production. 171 
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CHO oxidation (g·min-1) = 4.585 V̇CO2 (L·min-1) - 3.226 V̇O2 (L·min-1) 172 
Fat oxidation (g·min-1) = 1.695 V̇O2 (L·min-1) - 1.701 V̇CO2 (L·min-1) 173 
Rates of FA oxidation (µmol·kg·min-1) were determined by converting the rate of 174 
triacylglycerol oxidation (g·kg·min-1) to its molar equivalent, assuming the average 175 
molecular mass of human triacylglycerol to be 855.3 g·mol-1, and multiplying the molar rate 176 
of triacylglycerol oxidation by three, because each molecule contains 3 µmol FA. Rates of 177 
CHO oxidation (µmol·kg·min-1) were determined by converting the rate of CHO oxidation 178 
(g·min-1) to its molar equivalent assuming 6 mol of O2 are consumed and 6 mol of CO2 179 
produced for each mol (180 g) oxidized. Total energy expenditure was estimated for each 180 
trial assuming an energy yield of 17.57 kJ and 39.33 kJ for 1 g of CHO and fat respectively.  181 
Statistical analysis 182 
 Statistical analysis was undertaken using SPSS (Version 20 for Windows, SPSS Inc, 183 
Chicago, IL). Data from the 4 trials were analyzed using a linear mixed model (time x 184 
treatment). When a significant main effect was reported, a one way ANOVA was used (time 185 
or treatment) with Bonferroni post hoc analysis. Statistical significance was set at P<0.05. All 186 
data are represented as mean ± SD. Data for distance run was also analyzed for magnitude-187 
based effect sizes between conditions using a custom spreadsheet (19). Data was log-188 
transformed to account for non-uniformity and effect size ± 90% confidence interval (ES ± 189 
90% CI) calculated and classified as either trivial (-0.2-0.2, ES) small (0.2-0.6 ES), moderate 190 
(0.6-1.2 ES) or large (1.2-2 ES).  Where the 90% CI overlapped small positive (0.2) and 191 
negative (-0.2) values, the effect was considered “unclear”. 192 
 193 
 194 
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Results 195 
Twelve participants commenced this study but one participant was unable to complete 196 
the FAST trial due to illness, while another participant did not complete two of the prescribed 197 
performance trials with NA ingestion (CFED-NA and FAST-NA) due to side effects (i.e. 198 
dizziness, abdominal cramps). The pre-exercise data for the latter two trials have been 199 
included in analyses.    200 
Running distance covered  201 
There were small but statistically non-significant differences in the distance run such that 202 
CFED > CFED-NA > FAST > FAST-NA (Figure 2; P=0.067). ES statistics revealed a 203 
moderate reduction in distance run in FAST-NA (ES -0.96 ± 0.61) compared to CFED and a 204 
small reduction in FAST compared to CFED (ES -0.54 ± 0.65). The difference in distance 205 
run in CFED vs CFED-NA and FAST vs FAST-NA was “unclear” (ES -0.24 ± 0.64; -0.16 ± 206 
0.53 respectively). No difference was measured for the time to completion between trials 207 
(Table 2; P=0.053).   208 
Blood metabolites  209 
 A significant treatment x time interaction was observed for both plasma FFA 210 
(P<0.001) and plasma glycerol concentrations (P<0.01) from rest until post exercise (Figure 211 
3). There was no difference in FFA or glycerol concentrations at rest between treatments. The 212 
ingestion of NA suppressed lipolysis and blunted the typical exercise-induced increase in 213 
FFA concentrations in the CFED-NA and FAST-NA trials. Following the onset of exercise, 214 
FFA concentrations remained higher in the FAST trial compared to the CFED, CFED-NA 215 
and FAST-NA trials until the completion of exercise (Figure 3A; P<0.05). FFA 216 
concentrations increased in the CFED trial between 60 and 80 min of exercise (P<0.05) but 217 
such an increase was not observed in the CFED-NA trial. FFA concentrations were lower in 218 
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the CFED than the FAST trial post exercise (0.29 ± 0.05 vs. 0.50 ± 0.21 mmol·L-1 219 
respectively, P<0.001). Following 20 min of exercise, glycerol concentrations remained 220 
higher in the FAST trial than the CFED, CFED-NA and FAST-NA trials until exercise 221 
completion (Figure 3B; P<0.05). Increases in glycerol concentrations during the first 40 min 222 
of exercise were similar in the CFED, CFED-NA and FAST-NA trials. From 60 min of 223 
exercise, glycerol concentrations continued to elevate in the CFED trial until post exercise 224 
(0.46 ± 0.16 to 0.54 ± 0.18 mmol·L-1, P<0.05), such that they remained significantly higher 225 
than the CFED-NA trial during this period (P<0.01).  226 
A significant treatment x time interaction was observed for blood glucose and lactate 227 
concentrations (Figure 4; P<0.001).  Glucose concentrations increased above rest following 228 
the ingestion of a CHO meal in the CFED and CFED-NA trials (Figure 4A; CFED: 1.80 ± 229 
0.39; CFED-NA: 1.67 ± 0.50 mmol·L-1, P<0.001). Thereafter a decrease in glucose 230 
concentrations to below rest was observed in the CFED and CFED-NA trials until exercise 231 
commenced (P<0.001).  At 20 min of exercise, glucose concentrations were lower in the 232 
CFED and CFED-NA trials compared to the FAST and FAST-NA trials (P<0.02). In all 4 233 
trials, glucose concentrations increased until 40 min of exercise and remained relatively 234 
stable thereafter until post exercise. 235 
For all performance trials, lactate concentrations increased in the first 20 min of 236 
exercise above baseline (Figure 4B), where FAST was lower than CFED, CFED-NA and 237 
FAST-NA trials (P<0.02) and CFED-NA was higher than the CFED trial (P<0.02). From 20 238 
to 80 min of exercise no change was observed in lactate concentrations in the CFED, FAST 239 
and FAST-NA trials, although there was a decrease in the CFED-NA trial (3.24  ± 0.68 to 240 
2.54  ± 1.24 mmol·L-1, P<0.001). No difference was observed in post-exercise lactate 241 
concentrations between treatments. 242 
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CHO and fat oxidation during exercise 243 
Rates of whole body CHO oxidation were similar in the CFED, CFED-NA and 244 
FAST-NA trials, but were lower in FAST compared to the CFED-NA trial (338.48 ± 34.71 245 
vs. 297.15 ± 45.88 umol·kg·min-1, respectively, P=0.010), such that there was a main 246 
treatment effect (P=0.007). Rates of fat oxidation were higher in the FAST trial compared to 247 
the CFED-NA trial (16.78 ± 8.74 vs. 8.92 ± 6.65 umol·kg·min-1, P=0.023) and there was a 248 
main effect of treatment (P=0.008). No difference in fat oxidation was observed in the CFED, 249 
CFED-NA and FAST-NA trials.  250 
There was a significant effect of treatment for total CHO oxidized during each trial 251 
(P<0.001) but no difference for total fat oxidized. Total CHO oxidation was lower in the 252 
FAST trial in comparison to the CFED and CFED-NA trials (310.22 ± 49.95 vs. 358.48 ± 253 
46.36 vs. 371.89 ± 27.06 g, P=0.025, P=0.002 respectively). Estimated total energy 254 
expenditure was lower in the FAST trial than the CFED-NA trial (6539 ± 747 vs. 7164 ± 609 255 
kJ, P=0.011), as such there was a significant effect of treatment (P=0.010) on estimated total 256 
energy expenditure. 257 
Respiratory parameters and RPE 258 
 There was a main effect of time (P=0.042) and treatment (P=0.004) for RER (Figure 259 
5). RER was lower in the FAST trial compared to the CFED-NA trial (0.94 ± 0.03 vs. 0.97 ± 260 
0.02, P=0.016) although no difference in RER was observed within the CFED (0.96 ± 0.03) 261 
and CFED-NA trials or the FAST and FAST-NA (0.96 ± 0.02) trials.  262 
There was no difference in relative exercise intensity between the 4 trials (P=0.137) 263 
(Table 2). There was a main effect of time for V̇O2 and V̇CO2, HR, RR and RPE for all trials 264 
(P<0.05), but no treatment effect for these variables (Table 2).  VO2 and VCO2 increased in 265 
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the 4 trials from 60 min to exercise completion (3.55 ± 0.38 to 3.62 ±0.38, 3.38 ± 0.36 to 3.46 266 
± 0.40 L.min-1 respectively, P<0.05) and HR, RR and RPE increased from 20 min to exercise 267 
completion (165 ± 8 to 173 ± 9 bpm, 44 ± 6 to 51 ± 9 bpm, 13 ± 1 to 17 ± 2, respectively, 268 
P<0.05).  269 
Fluid intake, body mass loss and gastrointestinal distress 270 
 There were no differences in the average fluid consumed (330 ± 171 mL, P=0.680) or 271 
loss in BM (1.73 ± 0.32 kg, P=0.081) during the 4 experimental trials. No significant 272 
difference was reported between trials (P=0.241), with gastrointestinal stress rated as ‘no 273 
problem at all’ in the CFED and FAST trials to ‘very very minor’ in the CFED-NA and 274 
FAST-NA trials.  275 
 Discussion 276 
The novel finding of the present study was that the suppression of lipolysis and the 277 
exercise-induced increase in plasma FFA concentrations via NA ingestion did not impair 278 
half-marathon running capacity in competitive male athletes. Indeed, regardless of substrate 279 
priming by pre-event nutrition (a CHO-rich pre-race meal or following an overnight fast), 280 
intense exercise was CHO-dependent, with fat oxidation providing only a small contribution 281 
towards total energy expenditure. This is the first study to administer NA to well-trained 282 
runners to suppress blood-borne FA availability during high-intensity running.  283 
A primary goal of the current investigation was to determine whether blunting the 284 
normal exercise-induced rise in plasma FFA would have a detrimental effect on the 285 
performance of an endurance running event (viz. half marathon) in competitive athletes.  286 
Although time to fatigue protocols measure exercise capacity rather than performance per se, 287 
the protocol implemented in this study was necessary to allow steady-state measures of 288 
whole-body rates of substrate oxidation. Our primary finding of no difference in the running 289 
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distance covered between the four trials when running at ~80% V̇O2max (Figure 1) supports 290 
our original hypothesis that fat oxidation plays only a minor role in endurance events lasting 291 
~90 min when CHO availability is high.  We observed a step-wise reduction in the mean 292 
distance covered whereby CFED > CFED-NA > FAST > FAST-NA, although such 293 
differences failed to reach statistical significance. Indeed, ES statistics revealed small to 294 
moderate reductions in performance when exercising fasted or fasted with NA compared to 295 
when CHO fed, respectively. The small decrement in distance covered measured in the 296 
overnight fasted trials in comparison to the CHO fed trials (6.6%) supports the importance of 297 
ingesting CHO in the hours prior to and during high-intensity running to increase CHO 298 
availability, turnover and oxidation rates and ultimately optimise performance. Indeed, it has 299 
long been know that high CHO availability can delay the onset of fatigue during prolonged 300 
intense exercise (10). While a ~7% difference in the distance covered appears a worthwhile 301 
improvement for an athlete, it is important to note that the magnitude of the increase in 302 
distance covered in the trials in which pre-exercise CHO was consumed was well below the 303 
10-15%, which has been estimated as a meaningful variation when using a time to volitional 304 
fatigue trial of similar exercise duration (20). 305 
The majority of studies which have previously investigated the NA-induced 306 
suppression of fat availability on exercise performance have focussed on cycling protocols (5, 307 
14, 21, Torrens S.L. et al., unpublished observations). Torrens S.L. et al. (unpublished 308 
observations) reported no difference in cycling performance when participants completed a 309 
90 min cycling time trial (TT) (~300 W, 82% V̇O2max) following the ingestion of NA in a 310 
CHO-fed state in comparison to a control trial. Equally, no differences in cycling 311 
performance were observed during a ~30 min cycling TT (320 W, ~80% V̇O2max) or a 3.5 312 
mile cycling TT (~12 min) when NA was ingested in a CHO-fed state in comparison to a 313 
control trial (16, 25). The findings of these studies might be considered predictable, based on 314 
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the nature (short duration, high-intensity) or mode (cycling) of exercise, both of which favour 315 
high rates of CHO oxidation (1, 8, 24, 31).  The current study adds to the body of knowledge 316 
by confirming the importance of CHO as a substrate for sporting activities at higher exercise 317 
intensities and during running, where it is recognised that rates of fat oxidation are higher at 318 
the same relative intensities than observed during cycling (1, 8).  The half-marathon event 319 
was chosen for investigation because endogenous fat and CHO stores would be highly 320 
available as energy substrates under control conditions (15) and thus a change in performance 321 
and fuel use associated with a change in substrate availability would indicate the importance 322 
of this fuel source.  323 
The second major finding of the current study was that participants were reliant on 324 
CHO substrates to fuel muscular work under all experimental conditions as indicated by the 325 
predominant contribution of CHO to total energy expenditure (83-91%, Figure 6). The mean 326 
rates of CHO oxidation for all four conditions was ~4 g·min-1 which amounts to a total of 327 
~350 g of CHO for the exercise task (Table 1). Such a value is well within the 400-500 g of 328 
muscle glycogen stored from the CHO loading diet (8 g·kg·BM-1 CHO) consumed by the 329 
trained runners in the 24 h prior to our half-marathon protocol (15). We note that the absolute 330 
rates of CHO oxidation in the present study are substantially higher than those reported by 331 
Lee et al. (23) during a half-marathon in which CHO was consumed. However, the well-332 
trained status and faster running speeds (~15 km·h-1 vs. 12.2 km·h-1) of our participants along 333 
with the higher energy demand of exercise explains such differences.  Greater amounts of 334 
CHO (~55 g) were oxidized in the trials involving pre-exercise CHO intake compared to 335 
overnight-fasted conditions; this is explained by greater CHO availability and the priming of 336 
the hormonal environment to increase rates of CHO utilization (11). The blunting of FFA 337 
availability with NA led to an equal increase in total CHO oxidation, regardless of pre-338 
exercise CHO intake. However, even under conditions that should favour fat oxidation 339 
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(overnight fasting, absence of exogenous CHO intake during exercise), CHO remained the 340 
predominant fuel source (83 % total energy expenditure).   341 
It has long been known that the ingestion of NA alters fuel availability and hence 342 
muscle substrate selection during exercise (5). A blunting of the typical exercise-induced rise 343 
in FFAs has been demonstrated in previous studies that have administered NA in cycling 344 
protocols (16, 25) and was clearly demonstrated in the present study, independent of CHO 345 
status (Figure 3). However, there was an additive effect of pre-exercise CHO and NA on fat 346 
metabolism during exercise, as evidenced by the reduction in plasma FFA and glycerol 347 
concentrations after 60 min and 80 min of running, respectively, compared to pre-exercise 348 
CHO feeding alone. These findings support the results of Murray et al. (25) who reported 349 
higher circulating plasma FFAs during submaximal cycling (~70% V̇O2max) when ingesting 350 
CHO compared to the co-ingestion of CHO plus NA. Although the administration of NA in 351 
the current study suppressed adipose tissue lipolysis as evidenced by the reduction in plasma 352 
FFAs, total fat oxidation during the running protocol was estimated to be ~21 g with no 353 
difference observed between trials (Table 1). As there was only a small contribution from 354 
plasma FFAs to total fat utilized, it is likely that a large proportion of the fat oxidized was 355 
from intramuscular triglycerides (IMTG) (24, 31). Consequently, the small yet obligatory 356 
contribution of endogenous fat substrates when running at high intensity, irrespective of 357 
nutritional status pre-exercise should not go unrecognized.  358 
Bergstrom et al. (5) reported higher respiratory quotient (RQ) values measured via 359 
arteriovenous oxygen difference across the working leg and thus greater CHO utilization 360 
during submaximal cycling exercise following administration of NA compared to a control 361 
trial. The higher RQ was associated with a 33% increase in muscle glycogen utilization, 362 
greater arterial blood lactate concentrations and a reduction in arterial FFA and glycerol 363 
concentrations. The measurement of whole body RER in the present study makes it difficult 364 
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to isolate the energy contribution from individual CHO sources. However, NA ingestion was 365 
associated with a greater increase in blood lactate concentrations at the onset of exercise, 366 
regardless of the effect of pre-exercise CHO intake on lowering blood glucose concentrations 367 
(Figure 4). This provides indirect evidence for a greater reliance on endogenous CHO 368 
sources (i.e. muscle and liver glycogen) as previously reported (5). 369 
When investigating the interaction between training status, exercise intensity and pre-370 
exercise nutritional state on substrate oxidation, Bergman and Brooks (3) reported that 371 
substrate oxidation during graded cycling was largely determined by the relative intensity of 372 
exercise. O’Brien et al. (26) have also previously demonstrated the importance of exercise 373 
intensity during simulated marathon running in ‘fast’ (completion time ≤2 h, 43 min, 73% 374 
V̇O2max) or ‘slow’ (completion time ≤3 h, 30 min, 65% V̇O2max) runners. These workers 375 
reported RER values and energy contribution from CHO substrates were significantly higher 376 
throughout the marathon in the faster runners (0.99, ~85-90% vs. 0.90, ~60-70%), even under 377 
conditions in which rates of fat oxidation would be expected to be maximized (i.e., overnight 378 
fasted, no CHO feeding during exercise).  While a recent study has highlighted the 379 
importance of fat oxidation during high-intensity exercise (18), the results of that 380 
investigation should be interpreted with caution. Hetlelid et al. (18) reported that RER values 381 
during interval run training (6 x 4 min work bouts at ~90-94% of V̇O2max) were reduced in 382 
well trained compared to recreational runners (0.88 vs. 0.95, respectively). However, these 383 
workers failed to demonstrate steady-state conditions during exercise, or correct for 384 
bicarbonate kinetics, so it is not known if breath V̇O2, and V̇CO2 values accurately reflect 385 
tissue oxygen consumption and CO2 production (12). Furthermore, even if the rates of fat 386 
oxidation were valid in that study (18), they would still only contribute a maximum of 38% 387 
of total energy expenditure in their well trained runners (18), demonstrating CHO rather than 388 
fat dependence. Our results support the original findings of O’Brien et al (24), who reported 389 
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CHO dependency in both CHO fed and overnight fasted conditions when running a half-390 
marathon, and further reinforce the fact that when highly trained athletes compete in 391 
endurance events lasting up to 3 h, CHO-, not fat-based fuels are the predominant fuel for the 392 
working muscles and CHO, not fat availability becomes rate limiting for performance (17). 393 
In conclusion, the results of the current study show that well-trained runners are CHO 394 
dependent when running a half-marathon at race pace. Furthermore, when CHO availability 395 
is high, blunting the exercise-induced increase in FFA via NA ingestion did not impair 396 
intense exercise capacity in competitive athletes. During exercise of this intensity and 397 
duration, fat oxidation constitutes only a small percentage of overall energy expenditure 398 
independent of pre-event CHO status and CHO availability during exercise. While there is a 399 
small but obligatory use of fat-based fuels during intense endurance exercise lasting ~90 min, 400 
the oxidation of CHO-based fuels predominate. Therefore, endurance athletes should 401 
undertake dietary strategies that ensure high-CHO availability before and during competition 402 
to maximise rates of CHO oxidation and optimise race performance. 403 
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Figure Legends 514 
Figure 1. Schematic figure of study design.  CHO, carbohydrate; PLC, placebo, NA, 515 
nicotinic acid. 516 
Figure 2. Running distance covered during experimental trials. CFED, carbohydrate trial; 517 
CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted trial; FAST-NA, fasted with 518 
nicotinic acid trial. Values are means ± SD.  519 
Figure 3. Plasma FFA (A) and glycerol concentrations (B) during all experimental trials. 520 
CFED, carbohydrate trial; CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted 521 
trial; FAST-NA, fasted with nicotinic acid trial. Values are means ± SD. Significantly 522 
different (P<0.05), *FAST to CFED, CFED-NA, FAST-NA; a CFED, CFED-NA, FAST-NA 523 
to rest, b CFED to CFED-NA, c FAST to rest. 524 
Figure 4. Blood glucose (A) and lactate (B) concentrations during all experimental trials. 525 
CFED, carbohydrate trial; CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted 526 
trial; FAST-NA, fasted with nicotinic acid trial. Values are means ± SD.  Significantly 527 
different (P<0.05), *CFED & CFED-NA to FAST & FAST-NA; a CFED, CFED-NA, FAST-528 
NA to rest, b CFED to CFED-NA, # FAST to FAST-NA, ^ FAST to CFED, CFED-NA, 529 
FAST-NA. 530 
Figure 5. Respiratory exchange ratio during all experimental trials. CFED, carbohydrate trial; 531 
CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted trial; FAST-NA, fasted with 532 
nicotinic acid trial. Values are means ± SD.  Significantly different between treatments 533 
(P<0.05), *CFED-NA to FAST.  534 
Figure 6. Estimated energy expenditure during half-marathon running for all experimental 535 
trials. CFED, carbohydrate trial; CFED-NA, carbohydrate with nicotinic acid trial; FAST, 536 
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fasted trial; FAST-NA, fasted with nicotinic acid trial. Values are means ± SD. Significantly 537 
different between treatments (P<0.05), *CFED-NA to FAST.538 
539 
Table 1. Metabolic responses for the four experimental trials 540 
 541 
 542 
 543 
 544 
 545 
 546 
  547 
 548 
 549 
 550 
Treatment CHO  (g·min-1) 
Fat  
(g·min-1) 
CHO  
(umol·kg.min-1) 
Fat  
(umol·kg.min-1) 
Total CHO  
(g) 
Total Fat  
(g) 
Total Energy 
Expenditure 
(kJ) 
CFED  4.15 ± 0.57 0.25 ± 0.18 322.02 ± 43.77 11.82 ± 8.51 358.48 ± 46.36* 20.98 ± 13.64 7123 ± 804 
CFED-NA 4.36 ± 0.46* 0.19 ± 0.15* 338.48 ± 34.71* 8.92 ± 6.65* 371.89 ± 27.06* 16.02 ± 11.26 7164 ± 609* 
FAST  3.80 ± 0.70 0.34 ± 0.17 297.15 ± 45.88 16.78 ± 8.74 310.22 ± 49.95 27.68 ± 14.14 6539 ± 747 
FAST-NA 4.17 ± 0.57 0.23 ± 0.16 324.28 ± 38.04 11.34 ± 7.47 337.43 ± 35.71 18.62 ± 12.35 6661 ± 769 
CFED, carbohydrate trial; CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted trial; FAST-NA, fasted with nicotinic acid trial.  Values are 
means ± SD *Significantly different to FAST trial (P<0.05).   
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Table 2. Respiratory parameters, RPE and average run time until completion for the four experimental trials 551 
 552 
Treatment V̇O2  (L·min-1) 
V̇CO2  
(L·min-1) 
HR 
(bpm) 
RR 
(bpm) RPE 
Time 
(min) 
%  V̇O2max 
CFED  3.57 ± 0.42 3.41 ± 0.38 167 ± 9 46 ± 9 14 ± 1 1:26:32 ± 0:06:01 78.5 ± 3.7 
CFED-NA 3.61 ± 0.39 3.49 ± 0.34 170 ± 9 47 ± 7 15 ± 1 1:25:32 ± 0:03:49 79.7 ± 3.4 
FAST  3.51 ± 0.39 3.33 ± 0.46 169 ± 10 47 ± 7 15 ± 2 1:23:10 ± 0:05:41 77.8 ± 5.1 
FAST-NA 3.56 ± 0.37 3.42 ± 0.36 169 ± 11 47 ± 8 15 ± 2 1:20:57 ± 0:08:08 79.1 ± 3.7 
CFED, carbohydrate trial; CFED-NA, carbohydrate with nicotinic acid trial; FAST, fasted trial; FAST-NA, fasted with nicotinic acid trial. V̇O2, 
oxygen uptake; V̇CO2, carbon dioxide production; HR, heart rate; RR, respiratory rate; RPE, rate of perceived exertion; % V̇O2max, percentage 
of maximal oxygen uptake. Values are means ± SD. 
